Novartis Settles U.S. Fraud Lawsuit Over Sham Speaker Programs
NEW YORK — Novartis AG agreed to pay $678 million to settle a civil fraud lawsuit brought by the U.S. government accusing the Swiss drugmaker of paying millions of dollars in kickbacks to doctors to induce them to prescribe its …